Status:
UNKNOWN
Knee Osteoarthritis: Platelet Rich Plasma or Hyaluronic Acid
Lead Sponsor:
Antalya Training and Research Hospital
Collaborating Sponsors:
The Scientific and Technological Research Council of Turkey
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
50-70 years
Phase:
NA
Brief Summary
PURPOSE: To compare the effect of hyaluronic acid (HA) or platelet-rich plasma (PRP) on pain, physical function, quality of life and knee joint morphology in patients with knee osteoarthritis severity...
Detailed Description
PROJECT TEAM N.Fusun Toraman (NFT) cell phone: +90 505 355 9045 e.mail: fusuntoraman@gmail.com Meral Bilgilisoy Filiz (MBF) cell phone: +90 505 647 5840 e.mail: mbilgilisoy@gmail.com Aslı Karadag Ozde...
Eligibility Criteria
Inclusion
- Between 50-70 years of age
- Kellgren Lawrence (KL) radiological grade II-III knee OA
- Sedanter
- Unilateral knee pain
- Volunteer
Exclusion
- KL radiological grade ≥2 of contrlateral knee
- Thrombocytopenia (\<150.000/mm3)
- Coagulopathy
- Osteoarthritis of multiple joints
- Acute exacerbation of any joint
- Intraarticular steroid, PRP or HA injection within 6 months
- Non-steroidal anti inflammatory drugs or steroid use within 6 weeks
- Diabetes and cancer
- Severe anemia (hemoglobin \<10)
- Presence of heart and lung disease that can not perform physical function tests
- Secondary inflammatory arthritis
- Knee surgery or knee injury
- Planning for joint replacement within the next 3 months
- Difficulty in answering the questionnaires
- Limitation in joint range of motion
- Presence of genu varum / valgum \>50.
Key Trial Info
Start Date :
January 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 7 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03801564
Start Date
January 7 2019
End Date
March 7 2020
Last Update
July 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Naciye Fusun Toraman
Antalya, Turkey (Türkiye), 07100